Quoin Pharmaceuticals annual free cash flow
2017
2019
2020
2021
2022
Quoin Pharmaceuticals Free Cash Flow (FCF) History (QNRX)
Quoin Pharmaceuticals reported −$8.7M in free cash flow for fiscal 2022, a decrease of $2.4M from the previous fiscal year.
View full Quoin Pharmaceuticals company overviewQuoin Pharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2022 | 2022-12-31 | −$8.7M | −$2.4M | — | — |
| 2021 | 2021-12-31 | −$6.3M | −$4.9M | — | — |
| 2020 | 2020-12-31 | −$1.4M | −$106,775 | — | — |
| 2019 | 2019-12-31 | −$1.3M | — | — | — |
| 2017 | 2017-12-31 | −$5.2M | — | — | — |
Quoin Pharmaceuticals free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$5.2M to −$8.7M, a net decrease of $3.5M.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Quoin Pharmaceuticals source filings ↗